Disease / condition

Diabetic Macular Edema clinical trials

Free access to 301 studies·10+ countries·Updated daily42 recruiting
301
Total trials
10+
Countries
10+
Sponsors
42
Recruiting
By phase
N/A88
Phase 260
Phase 346
Phase 446
Early Phase 130
By status
Completed166
Recruiting42
Unknown40
Not yet recruit...24
Withdrawn14
Top countries
United States of America80
China23
Canada10
Iran10
Brazil10
Top sponsors
Novartis Pharmaceu...13
Jaeb Center for He...11
Shahid Beheshti Un...8
Hoffmann-La Roche8
Allergan7
Recent trials
Latest clinical trials for Diabetic Macular Edema
NCT06316388Not yet recr...
Outcomes After Vitrectomy in Eyes With Tractional Diabetic Macular Edema
Rehab Azzam
NCT06314217Recruiting
Everads Injector in Suprachoroidal Administration of TA Suspension, for Treatment of Patients With DME
Everads TherapyIsrael
NCT06305143·Phase 4Recruiting
Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy
Shanghai Eye Disease Preventio...China
NCT06237777·Phase 1Recruiting
A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients
Wang MinChina
NCT06205979·Phase 1Recruiting
Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
Sohag UniversityEgypt
NCT06099184·Phase 2Not yet recr...
Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
EyePoint Pharmaceuticals, Inc.
NCT05978622Not yet recr...
Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant
AbbVie
NCT05966753Not yet recr...
Describing Patient With DME, Their Patient Journey and Disease Progression
Boehringer Ingelheim
NCT05959304Not yet recr...
Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.
Novartis Pharmaceuticals
NCT05916391·Phase 1Recruiting
Gene Therapy for Diabetic Macular Edema
Frontera TherapeuticsChina
NCT05885503·Phase 3Not yet recr...
Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular Edema
RemeGen Co., Ltd.
NCT05940428·Phase 1Not yet recr...
A Study of ASKG712 in Patients With Diabetic Macular Edema
AskGene Pharma, Inc.China
NCT05861466·Phase 4Recruiting
Comparative Study Between IVI of Ranibizumab With and Without Prior ACP in Patients With DME Using OCT-A
Ain Shams UniversityEgypt
NCT05847088Completed
Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema:
Dar El Oyoun HospitalEgypt
NCT05815212Completed
Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial Intensive Treatment in the Real World Clinical Setting in Korea (Rising K)
Novartis PharmaceuticalsSouth Korea
NCT05736081·Phase 2/3Completed
Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema
Asociación para Evitar la Cegu...Mexico
NCT05727891·Phase 2Not yet recr...
Evaluation of Tonabersat for DME
Jaeb Center for Health Researc...
NCT05731089Completed
IVI Aflibercept Before and After Phaco in DME.
Al Hadi HospitalKuwait
NCT05712720·Phase 2Recruiting
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
RezoluteUnited States of America
NCT05715385·Phase 4Completed
Comparison of Treatments in Diabetic Macular Edema
Babasaheb Ambedkar Memorial Ho...
About this record

Access comprehensive clinical trial information for Diabetic Macular Edema through Pure Global AI's free database. This collection includes 301 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 42 trials are actively recruiting participants.

Research for Diabetic Macular Edema is being conducted in United States of America, China, Canada and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Jaeb Center for Health Research. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 301 clinical trials studying Diabetic Macular Edema, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Novartis Pharmaceuticals, Jaeb Center for Health Research, Shahid Beheshti University of Medical Sciences, among others.